2.134.653 (B) (7215254). - 28 AVRIL 1972. DERIVES DE BLEOMYCINES PORTANT UN SUBSTITUANT SUR L'AZOTE, ET LEUR PROCEDE DE PREPARATIONsdPatent

INHIBITION OF THE LETHALITY OF BLEOMYCIN A₅ IN L-CELLS BY HIRUDONINE.LAPI L; COHEN SS.1977; CANCER RES.; U.S.A.; DA. 1977; VOL. 37; NO 5; PP. 1384-1388; BIBL. 12 REF.Article

Modification of a new high-performance liquid chromatographic method for bleomycin to separate epi-, iso-, desamido-, and unmodified analoguesKLETT, R. P; CHOVAN, J. P.Journal of chromatography. 1985, Vol 337, Num 1, pp 182-186, issn 0021-9673Article

RECENT STUDIES ON ANTIBIOTICS AND SMALL MOLECULAR IMMUNOMODULATORS WITH POTENTIAL USEFULNESS IN TREATING LUNG CANCER. I: ANTITUMOR ANTIBIOTICS AND THEIR DERIVATIVESUMEZAWA H.1982; INT. J. CLIN. PHARMACOL. THER. TOXICOL.; DEU; DA. 1982; VOL. 20; NO 1; PP. 12-18; BIBL. 22 REF.Article

ELECTROCHEMICAL AND ESR STUDIES ON CU(II) COMPLEXES OF BLEOMYCIN AND ITS RELATED COMPOUNDSISHIZU K; MURATA S; MIYOSHI K et al.1981; J. ANTIBIOT.; ISSN 0021-8820; JPN; DA. 1981; VOL. 34; NO 8; PP. 994-1000; BIBL. 18 REF.Article

A REVIEW OF CLINICAL STUDIES OF PEPLEOMYCINOKA S.1980; RECENT RESULTS CANCER RES.; ISSN 0080-0015; USA; DA. 1980; NO 74; PP. 163-171; BIBL. 16 REF.Article

QUENCHING OF FLUORESCENCE OF BLEOMYCINS BY FERROUS ION AND ITS CORRELATION WITH DNA-BREAKAGE ACTIVITYCHENG HSIUNG HUANG; GALVAN L; CROOKE ST et al.1979; BIOCHEMISTRY; USA; DA. 1979; VOL. 18; NO 13; PP. 2880-2887; BIBL. 36 REF.Article

BIOLOGICAL STUDIES ON THE DEGRADATION PRODUCTS OF 3-((S)-1'-PHENYL-ETHYLAMINO) PROPYLAMINOBLEOMYCIN: A NOVEL ANALOG (PEPLEOMYCIN)TAKAHASHI K; EKIMOTO H; AOYAGI S et al.1979; J. ANTIBIOT.; JPN; DA. 1979; VOL. 32; NO 1; PP. 36-42; BIBL. 12 REF.Article

Synthesis and biological properties of side-chain-modified bleomycinsVLOON, W. J; KRUK, C; PANDIT, U. K et al.Journal of medicinal chemistry (Print). 1987, Vol 30, Num 1, pp 20-24, issn 0022-2623Article

CHEMICAL AND BIOLOGICAL MODIFICATION OF BLEOMYCIN, AN ANTITUMOR ANTIBIOTICTAKITA T; MAEDA K.1980; J. HETEROCYCL. CHEM.; ISSN 0022-152X; USA; DA. 1980; VOL. 17; NO 8; PP. 1799-1802; BIBL. 12 REF.Article

CHEMISTRY OF BLEOMYCIN. XVI. EPI-BLEOMYCIN.MURAOKA Y; KOBAYASHI H; FUJII A et al.1976; J. ANTIBIOT.; JAP.; DA. 1976; VOL. 29; NO 8; PP. 853-856; BIBL. 11 REF.Article

EFFECT OF A BLEOMYCIN DERIVATIVE ON ORAL CARCINOMASUKUDA M; HIURA S; USUI M et al.1980; INTERNATION J. ORAL SURG.; DNK; DA. 1980; VOL. 9; NO 2; PP. 103-112; BIBL. 18 REF.Article

DNA strand scission by bleomycin group antibioticsSUGIYAMA, H; EHRENFELD, G. M; SHIPLEY, J. B et al.Journal of natural products (Print). 1985, Vol 48, Num 6, pp 869-877, issn 0163-3864Article

Total synthesis of deamido bleomycin A₂, the major catabolite of the antitumor agent bleomycinYING ZOU; NOUR EDDINE FAHMI; VIALAS, Corine et al.Journal of the American Chemical Society. 2002, Vol 124, Num 32, pp 9476-9488, issn 0002-7863Article

Phase I triel of tallysomycin S_10b, a bleomycin analoguePAOLOZZI, F. P; GAVER, R. C; NEWMAN, N. B et al.Investigational new drugs. 1990, Vol 8, Num 2, pp 171-180, issn 0167-6997, 10 p.Article

Solid-phase synthesis of bleomycin A₅ and three monosaccharide analogues: Exploring the role of the carbohydrate moiety in RNA cleavageTHOMAS, Craig J; CHIZHOV, Alexander O; LEITHEISER, Christopher J et al.Journal of the American Chemical Society. 2002, Vol 124, Num 44, pp 12926-12927, issn 0002-7863, 2 p.Article

Hyperthermic intravesical peplomycin perfusion treatment for bladder cancerUCHIBAYASHI, T; NAKAJIMA, K; HISAZUMI, H et al.British journal of urology (Print). 1993, Vol 72, Num 1, pp 65-67, issn 0007-1331Article

Man-designed bleomycins: synthesis of dioxygen activating molecules and a DNA cleaving molecule based on bleomycin-Fe(II)-O₂ complexKITTAKA, A; SUGANO, Y; OTSUKA, M et al.Tetrahedron (Oxford. Print). 1988, Vol 44, Num 10, pp 2821-2833, issn 0040-4020Article